Morphological and Physiological Characteristics of Ruptured Plaques in Native Arteries and Neoatherosclerotic Segments: An OCT-Based and Computational Fluid Dynamics Study.

computational fluid dynamics (CFD) endothelial shear stress neoatherosclerosis optical coherence tomography plaque rupture plaque structural stress

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 06 03 2022
accepted: 04 05 2022
entrez: 20 6 2022
pubmed: 21 6 2022
medline: 21 6 2022
Statut: epublish

Résumé

Intravascular imaging has been used to assess the morphology of lesions causing an acute coronary syndrome (ACS) in native vessels (NV) and identify differences between plaques that ruptured (PR) and caused an event and those that ruptured without clinical manifestations. However, there is no data about the morphological and physiological characteristics of neoatherosclerotic plaques that ruptured (PR-NA) which constitute a common cause of stent failure. We retrospectively analyzed data from patients admitted with an acute myocardial infarction that had optical coherence tomography (OCT) imaging of the culprit vessel before balloon pre-dilation. OCT pullbacks showing PR were segmented at every 0.4 mm. The extent of the formed cavity, lipid and calcific tissue, thrombus, and macrophages were measured, and the fibrous cap thickness (FCT) and the incidence of micro-channels and cholesterol crystals were reported. These data were used to reconstruct a representative model of the native and neoatherosclerotic lesion geometry that was processed with computational fluid dynamics (CFD) techniques to estimate the distribution of the endothelial shear stress and plaque structural stress. Eighty patients were included in the present analysis: 56 had PR in NV (PR-NV group) and 24 in NA segments (PR-NA group). The PR-NV group had a larger minimum lumen area (2.93 ± 2.03 vs. 2.00 ± 1.26 mm We reported significant morphological and physiological differences between culprit ruptured plaques in native and stented segments. Further research is needed to better understand the causes of these differences and the mechanisms regulating neoatherosclerotic lesion destabilization.

Sections du résumé

Background UNASSIGNED
Intravascular imaging has been used to assess the morphology of lesions causing an acute coronary syndrome (ACS) in native vessels (NV) and identify differences between plaques that ruptured (PR) and caused an event and those that ruptured without clinical manifestations. However, there is no data about the morphological and physiological characteristics of neoatherosclerotic plaques that ruptured (PR-NA) which constitute a common cause of stent failure.
Methods UNASSIGNED
We retrospectively analyzed data from patients admitted with an acute myocardial infarction that had optical coherence tomography (OCT) imaging of the culprit vessel before balloon pre-dilation. OCT pullbacks showing PR were segmented at every 0.4 mm. The extent of the formed cavity, lipid and calcific tissue, thrombus, and macrophages were measured, and the fibrous cap thickness (FCT) and the incidence of micro-channels and cholesterol crystals were reported. These data were used to reconstruct a representative model of the native and neoatherosclerotic lesion geometry that was processed with computational fluid dynamics (CFD) techniques to estimate the distribution of the endothelial shear stress and plaque structural stress.
Result UNASSIGNED
Eighty patients were included in the present analysis: 56 had PR in NV (PR-NV group) and 24 in NA segments (PR-NA group). The PR-NV group had a larger minimum lumen area (2.93 ± 2.03 vs. 2.00 ± 1.26 mm
Conclusion UNASSIGNED
We reported significant morphological and physiological differences between culprit ruptured plaques in native and stented segments. Further research is needed to better understand the causes of these differences and the mechanisms regulating neoatherosclerotic lesion destabilization.

Identifiants

pubmed: 35722127
doi: 10.3389/fcvm.2022.890799
pmc: PMC9204481
doi:

Types de publication

Journal Article

Langues

eng

Pagination

890799

Informations de copyright

Copyright © 2022 Jin, Torii, Ramasamy, Tufaro, Little, Konstantinou, Tan, Yap, Cooper, Crake, O’Mahony, Rakhit, Egred, Ahmed, Karamasis, Räber, Baumbach, Mathur and Bourantas.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1340-1350
pubmed: 30025727
JACC Cardiovasc Imaging. 2017 Jun;10(6):677-688
pubmed: 27665158
Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1070-3
pubmed: 8696948
EuroIntervention. 2015 Nov;11(7):746-56
pubmed: 25308301
Int J Cardiol. 2015;186:178-85
pubmed: 25828109
Eur Heart J. 2019 Nov 1;40(41):3421-3433
pubmed: 31566246
Circ Cardiovasc Interv. 2013 Oct 1;6(5):507-17
pubmed: 24065447
N Engl J Med. 2007 Apr 12;356(15):1503-16
pubmed: 17387127
Eur Heart J. 2015 Jun 7;36(22):1377-84
pubmed: 25713314
Nat Rev Cardiol. 2016 Feb;13(2):79-98
pubmed: 26503410
Int J Cardiol. 2018 Dec 1;272:7-12
pubmed: 30293579
Nat Clin Pract Cardiovasc Med. 2005 Sep;2(9):456-64
pubmed: 16265586
JACC Cardiovasc Imaging. 2019 Aug;12(8 Pt 1):1518-1528
pubmed: 30553686
JACC Cardiovasc Interv. 2014 Mar;7(3):315-24
pubmed: 24529931
Tex Heart Inst J. 2011;38(5):491-501
pubmed: 22163122
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):430-8
pubmed: 25550204
Atherosclerosis. 2019 Apr;283:79-84
pubmed: 30802681
J Am Coll Cardiol. 2021 Sep 21;78(12):1257-1265
pubmed: 34531027
Am Heart J. 2015 Sep;170(3):591-7
pubmed: 26385044
Am J Cardiol. 2006 Aug 15;98(4):429-35
pubmed: 16893692
Arterioscler Thromb Vasc Biol. 2020 Jan;40(1):220-229
pubmed: 31619064
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45
pubmed: 20359842
J Am Coll Cardiol. 2014 Jun 3;63(21):2209-16
pubmed: 24632266
Circ Cardiovasc Imaging. 2012 Sep 1;5(5):660-6
pubmed: 22798521
Eur Heart J. 2015 Aug 21;36(32):2167-76
pubmed: 26040806
EuroIntervention. 2016 Oct 10;12(8):e987-e997
pubmed: 27721214
Circ Cardiovasc Imaging. 2014 May;7(3):461-70
pubmed: 24557858
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2425-31
pubmed: 23887639
Atherosclerosis. 2012 Aug;223(2):321-6
pubmed: 22762729
Circ J. 2019 Dec 25;84(1):91-100
pubmed: 31735729
Circulation. 2003 Oct 14;108(15):1809-14
pubmed: 14530206
Lancet. 1989 Oct 21;2(8669):941-4
pubmed: 2571862
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2217-2224
pubmed: 30026269
Eur Heart J. 2017 Jan 7;38(2):81-92
pubmed: 28158723
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1166-1176
pubmed: 26117464
Biomech Model Mechanobiol. 2009 Dec;8(6):473-86
pubmed: 19294440
JACC Cardiovasc Interv. 2010 Sep;3(9):928-34
pubmed: 20850091
Eur Heart J. 2015 Aug 21;36(32):2147-59
pubmed: 25994755
EuroIntervention. 2018 Feb 02;13(15):e1831-e1840
pubmed: 28606888
J Am Coll Cardiol. 2021 Sep 21;78(12):1266-1274
pubmed: 34531028

Auteurs

Chongying Jin (C)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Ryo Torii (R)

Department of Mechanical Engineering, University College London, London, United Kingdom.

Anantharaman Ramasamy (A)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Vincenzo Tufaro (V)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Department of Biomedical Sciences, Humanitas University, Milan, Italy.

Callum D Little (CD)

Royal Free Hospital, University College London, London, United Kingdom.

Klio Konstantinou (K)

Essex Cardiothoracic Centre, Anglia Ruskin School of Medicine, Essex, United Kingdom.

Yi Ying Tan (YY)

Department of Mechanical Engineering, University College London, London, United Kingdom.

Nathan A L Yap (NAL)

Barts and The London School of Medicine and Dentistry, London, United Kingdom.

Jackie Cooper (J)

Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Tom Crake (T)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.

Constantinos O'Mahony (C)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Institute of Cardiovascular Science, University College London, London, United Kingdom.

Roby Rakhit (R)

Royal Free Hospital, University College London, London, United Kingdom.

Mohaned Egred (M)

Freeman Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom.

Javed Ahmed (J)

Freeman Hospital, Newcastle University, Newcastle upon Tyne, United Kingdom.

Grigoris Karamasis (G)

Essex Cardiothoracic Centre, Anglia Ruskin School of Medicine, Essex, United Kingdom.

Lorenz Räber (L)

Department of Cardiology, University of Bern, Bern, Switzerland.

Andreas Baumbach (A)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Yale University School of Medicine, New Haven, CT, United States.

Anthony Mathur (A)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Christos V Bourantas (CV)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Institute of Cardiovascular Science, University College London, London, United Kingdom.

Classifications MeSH